165 related articles for article (PubMed ID: 26770985)
1. Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.
Domingueti CP; Fóscolo RB; Reis JS; Campos FM; Dusse LM; Carvalho Md; Braga Gomes K; Fernandes AP
J Diabetes Res; 2016; 2016():2315260. PubMed ID: 26770985
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
Domingueti CP; Dusse LM; Fóscolo RB; Reis JS; Annichino-Bizzacchi JM; Orsi FL; Mazetto Bde M; Carvalho Md; Gomes KB; Fernandes AP
PLoS One; 2015; 10(7):e0132784. PubMed ID: 26168189
[TBL] [Abstract][Full Text] [Related]
3. Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus.
Domingueti CP; Fuzatto JA; Fóscolo RB; Reis JS; Dusse LM; Carvalho MDG; Gomes KB; Fernandes AP
Clin Chim Acta; 2016 Aug; 459():1-4. PubMed ID: 27208743
[TBL] [Abstract][Full Text] [Related]
4. Association between reduced ADAMTS13 and diabetic nephropathy.
Taniguchi S; Hashiguchi T; Ono T; Takenouchi K; Nakayama K; Kawano T; Kato K; Matsushita R; Nagatomo M; Nakamura S; Nakashima T; Maruyama I
Thromb Res; 2010 Jun; 125(6):e310-6. PubMed ID: 20307901
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
[TBL] [Abstract][Full Text] [Related]
6. Association of different biomarkers of renal function with D-dimer levels in patients with type 1 diabetes mellitus (renal biomarkers and D-dimer in diabetes).
Domingueti CP; Fóscolo RB; Dusse LMS; Reis JS; Carvalho MDG; Gomes KB; Fernandes AP
Arch Endocrinol Metab; 2018 Feb; 62(1):27-33. PubMed ID: 29694626
[TBL] [Abstract][Full Text] [Related]
7. Increased ADAMTS13 activity in patients with venous thromboembolism.
Mazetto BM; Orsi FL; Barnabé A; De Paula EV; Flores-Nascimento MC; Annichino-Bizzacchi JM
Thromb Res; 2012 Dec; 130(6):889-93. PubMed ID: 23031329
[TBL] [Abstract][Full Text] [Related]
8. Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy.
Pestana RM; Domingueti CP; Duarte RC; Fóscolo RB; Reis JS; Rodrigues AM; Martins LB; Sousa LP; Lage DP; Ferreira CN; Ferreira AV; Fernandes AP; Gomes KB
Immunol Res; 2016 Aug; 64(4):951-60. PubMed ID: 27307060
[TBL] [Abstract][Full Text] [Related]
9. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
10. Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis.
Cohen-Hagai K; Rashid G; Einbinder Y; Ohana M; Benchetrit S; Zitman-Gal T
Ann Lab Med; 2017 Mar; 37(2):155-158. PubMed ID: 28029003
[TBL] [Abstract][Full Text] [Related]
11. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
Ishikawa M; Uemura M; Matsuyama T; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Tsujimoto T; Takimura C; Fujimura Y; Fukui H
Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S25-33. PubMed ID: 19094193
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.
Rurali E; Noris M; Chianca A; Donadelli R; Banterla F; Galbusera M; Gherardi G; Gastoldi S; Parvanova A; Iliev I; Bossi A; Haefliger C; Trevisan R; Remuzzi G; Ruggenenti P;
Diabetes; 2013 Oct; 62(10):3599-609. PubMed ID: 23733198
[TBL] [Abstract][Full Text] [Related]
13. The correlation of inflammatory markers and plasma vaspin levels in patients with diabetic nephropathy.
Karadag S; Sakci E; Uzun S; Aydin Z; Cebeci E; Sumnu A; Ozkan O; Yamak M; Koldas M; Behlul A; Gursu M; Ataoglu E; Ozturk S
Ren Fail; 2016 Aug; 38(7):1044-9. PubMed ID: 27216464
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.
Silveira AM; Sjöberg S; Blombäck M; Ostman J
J Diabetes Complications; 1992; 6(2):89-95. PubMed ID: 1611144
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability and cardiovascular disease in diabetic nephropathy.
Domingueti CP; Dusse LM; Carvalho Md; Gomes KB; Fernandes AP
Clin Chim Acta; 2013 Jan; 415():279-85. PubMed ID: 23159842
[TBL] [Abstract][Full Text] [Related]
16. PTPN2 Downregulation Is Associated with Albuminuria and Vitamin D Receptor Deficiency in Type 2 Diabetes Mellitus.
Zheng L; Zhang W; Li A; Liu Y; Yi B; Nakhoul F; Zhang H
J Diabetes Res; 2018; 2018():3984797. PubMed ID: 30246029
[TBL] [Abstract][Full Text] [Related]
17. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
19. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.
Lacquemant C; Gaucher C; Delorme C; Chatellier G; Gallois Y; Rodier M; Passa P; Balkau B; Mazurier C; Marre M; Froguel P
Kidney Int; 2000 Apr; 57(4):1437-43. PubMed ID: 10760079
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis.
Rios DR; Carvalho MG; Figueiredo RC; Ferreira CN; Rodrigues VL; Souza RA; e Silva AC; Fernandes AP; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 Jul; 34(1):73-8. PubMed ID: 22298244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
